Keshavarzian A - Search Results

1

In vitro evaluation of intestinal epithelial TLR activation in preventing food allergic responses.

de Kivit S, Tobin MC, DeMeo MT, Fox S, Garssen J, Forsyth CB, Keshavarzian A, Landay AL. de Kivit S, et al. Among authors: keshavarzian a. Clin Immunol. 2014 Oct;154(2):91-9. doi: 10.1016/j.clim.2014.07.002. Epub 2014 Jul 21. Clin Immunol. 2014. PMID: 25058467

2

Erythromycin in chronic intestinal pseudo-obstruction.

Berger SA, Keshavarzian A, DeMeo MT, Mobarhan S. Berger SA, et al. Among authors: keshavarzian a. J Clin Gastroenterol. 1990 Jun;12(3):363. doi: 10.1097/00004836-199006000-00030. J Clin Gastroenterol. 1990. PMID: 2362109 No abstract available.

3

Intestinal permeation and gastrointestinal disease.

DeMeo MT, Mutlu EA, Keshavarzian A, Tobin MC. DeMeo MT, et al. Among authors: keshavarzian a. J Clin Gastroenterol. 2002 Apr;34(4):385-96. doi: 10.1097/00004836-200204000-00003. J Clin Gastroenterol. 2002. PMID: 11907349 Review.

4

Critical role of the atypical {lambda} isoform of protein kinase C (PKC-{lambda}) in oxidant-induced disruption of the microtubule cytoskeleton and barrier function of intestinal epithelium.

Banan A, Zhang LJ, Farhadi A, Fields JZ, Shaikh M, Forsyth CB, Choudhary S, Keshavarzian A. Banan A, et al. Among authors: keshavarzian a. J Pharmacol Exp Ther. 2005 Feb;312(2):458-71. doi: 10.1124/jpet.104.074591. Epub 2004 Sep 3. J Pharmacol Exp Ther. 2005. PMID: 15347733

5

theta Isoform of protein kinase C alters barrier function in intestinal epithelium through modulation of distinct claudin isotypes: a novel mechanism for regulation of permeability.

Banan A, Zhang LJ, Shaikh M, Fields JZ, Choudhary S, Forsyth CB, Farhadi A, Keshavarzian A. Banan A, et al. Among authors: keshavarzian a. J Pharmacol Exp Ther. 2005 Jun;313(3):962-82. doi: 10.1124/jpet.104.083428. J Pharmacol Exp Ther. 2005. PMID: 15900076

6

Mastocytic enterocolitis: increased mucosal mast cells in chronic intractable diarrhea.

Jakate S, Demeo M, John R, Tobin M, Keshavarzian A. Jakate S, et al. Among authors: keshavarzian a. Arch Pathol Lab Med. 2006 Mar;130(3):362-7. doi: 10.5858/2006-130-362-MEIMMC. Arch Pathol Lab Med. 2006. PMID: 16519565 Free article.

7

Regulation of oxidant-induced intestinal permeability by metalloprotease-dependent epidermal growth factor receptor signaling.

Forsyth CB, Banan A, Farhadi A, Fields JZ, Tang Y, Shaikh M, Zhang LJ, Engen PA, Keshavarzian A. Forsyth CB, et al. Among authors: keshavarzian a. J Pharmacol Exp Ther. 2007 Apr;321(1):84-97. doi: 10.1124/jpet.106.113019. Epub 2007 Jan 12. J Pharmacol Exp Ther. 2007. PMID: 17220428

8

Influence of dietary fiber on inflammatory bowel disease and colon cancer: importance of fermentation pattern.

Rose DJ, DeMeo MT, Keshavarzian A, Hamaker BR. Rose DJ, et al. Among authors: keshavarzian a. Nutr Rev. 2007 Feb;65(2):51-62. doi: 10.1111/j.1753-4887.2007.tb00282.x. Nutr Rev. 2007. PMID: 17345958 Review.

9

Evidence for non-chemical, non-electrical intercellular signaling in intestinal epithelial cells.

Farhadi A, Forsyth C, Banan A, Shaikh M, Engen P, Fields JZ, Keshavarzian A. Farhadi A, et al. Among authors: keshavarzian a. Bioelectrochemistry. 2007 Nov;71(2):142-8. doi: 10.1016/j.bioelechem.2007.03.001. Epub 2007 Mar 12. Bioelectrochemistry. 2007. PMID: 17428745

10

Phosphodiesterase 4 inhibitors and inflammatory bowel disease: emerging therapies in inflammatory bowel disease.

Keshavarzian A, Mutlu E, Guzman JP, Forsyth C, Banan A. Keshavarzian A, et al. Expert Opin Investig Drugs. 2007 Sep;16(9):1489-506. doi: 10.1517/13543784.16.9.1489. Expert Opin Investig Drugs. 2007. PMID: 17714033 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

439 results

Search Page

Filters